Cardiac Catheterization Market: By Procedure (Coronary Angioplasty, Balloon Septostomy), Types (Coronary Angiogram, Fractional Flow Reserve), Application (Heart Attack, Abnormal Stress Test), and End-User (Hospitals & Clinics) – Global Forecast Till 2027
ID: MRFR/MED/0466-HCR | August 2022 | Region: Global | 115 Pages
Table of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porterβs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
6. Global Cardiac catheterization Market, by Procedures
6.1 Introduction
6.2 Coronary Angioplasty
ο§ Market Estimates & Forecast, 2018β2027
ο§ Market Estimates & Forecast, by Region/Country, 2018β2027
6.3 Balloon Septostomy
ο§ Market Estimates & Forecast, 2018β2027
ο§ Market Estimates & Forecast, by Region/Country, 2018β2027
6.4 Catheter Ablation
ο§ Market Estimates & Forecast, 2018β2027
ο§ Market Estimates & Forecast, by Region/Country, 2018β2027
6.5 Bipolar Pacing
ο§ Market Estimates & Forecast, 2018β2027
ο§ Market Estimates & Forecast, by Region/Country, 2018β2027
6.6 Left Heart Catheterization
ο§ Market Estimates & Forecast, 2018β2027
6.7 Right Heart Catheterization
β’ Market Estimates & Forecast, 2018β2027
β’ Market Estimates & Forecast, by Region/Country, 2018β2027
6.8 Other
ο§ Market Estimates & Forecast, 2018β2027
ο§ Market Estimates & Forecast, by Region/Country, 2018β2027
7. Global Cardiac catheterization Market, by Types
7.1 Introduction
7.2 Coronary Angiogram
β’ Market Estimates & Forecast, 2018β2027
β’ Market Estimates & Forecast, by Region/Country, 2018β2027
7.3 Fractional Flow Reserve
β’ Market Estimates & Forecast, 2018β2027
β’ Market Estimates & Forecast, by Region/Country, 2018β2027
7.4 Intravascular Ultrasound
ο§ Market Estimates & Forecast, 2018β2027
ο§ Market Estimates & Forecast, by Region/Country, 2018β2027
7.5 Optical Coherence Tomography
β’ Market Estimates & Forecast, 2018β2027
β’ Market Estimates & Forecast, by Region/Country, 2018β2027
8. Global Cardiac catheterization Market, by Application
8.1 Introduction
8.2 Heart Attack
β’ Market Estimates & Forecast, 2018β2027
β’ Market Estimates & Forecast, by Region/Country, 2018β2027
8.3 Abnormal Stress Test
β’ Market Estimates & Forecast, 2018β2027
β’ Market Estimates & Forecast, by Region/Country, 2018β2027
8.4 Coronary Vasospasm
β’ Market Estimates & Forecast, 2018β2027
β’ Market Estimates & Forecast, by Region/Country, 2018β2027
8.5 Cardiac Arrhythmia
ο§ Market Estimates & Forecast, 2018β2027
ο§ Market Estimates & Forecast, by Region/Country, 2018β2027
8.6 Others
β’ Market Estimates & Forecast, 2018β2027
β’ Market Estimates & Forecast, by Region/Country, 2018β2027
9 Global Cardiac Catheterization Market, by End-User
9.1 Introduction
9.2 Hospitals and Clinics
β’ Market Estimates & Forecast, 2018β2027
β’ Market Estimates & Forecast, by Region/Country, 2018β2027
9.3 Others
β’ Market Estimates & Forecast, 2018β2027
β’ Market Estimates & Forecast, by Region/Country, 2018β2027
10 Global Cardiac Catheterization Market, by Region
10 1 Introduction
10 2 Americas
β’ Market Estimates & Forecast, by Region, 2018β2027
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 2.1 North America
β’ Market Estimates & Forecast, by Country, 2018β2027
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 2.1.1 US
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 2.1.2 Canada
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 2.2 South America
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 3 Europe
β’ Market Estimates & Forecast, by Region, 2018β2027
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 3.1 Western Europe
β’ Market Estimates & Forecast, by Country, 2018β2027
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 3.1.1 Germany
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 3.1.2 France
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 3.1.3 UK
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 3.1.4 Italy
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 3.1.5 Spain
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 3.1.6 Rest of Western Europe
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 3.2 Eastern Europe
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 4 Asia-Pacific
β’ Market Estimates & Forecast, by Country, 2018β2027
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 4.1 Japan
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 4.2 China
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 4.3 India
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 4.4 Australia
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 4.5 Republic of Korea
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 4.6 Rest of Asia-Pacific
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 5 The Middle East & Africa
β’ Market Estimates & Forecast, by Region, 2018β2027
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 5.1 United Arab Emirates
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 5.2 Saudi Arabia
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 5.3 Oman
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 5.4 Kuwait
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 5.5 Qatar
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
10 5.6 Rest of the Middle East & Africa
β’ Market Estimates & Forecast, by Procedures, 2018β2027
β’ Market Estimates & Forecast, by Types, 2018β2027
β’ Market Estimates & Forecast, by Application, 2018β2027
β’ Market Estimates & Forecast, by End-User, 2018β2027
11 Company Landscape
11 .1 Introduction
11 .2 Market Share Analysis
11 .3 Key Development & Strategies
11 .3.1 Key Developments
12 Company Profiles
12 .1 Becton, Dickinson And Company
12 .1.1 Company Overview
12 .1.2 Product Overview
12 .1.3 Financials
12 .1.4 SWOT Analysis
12 .2 Boston Scientific Corporation
12 .2.1 Company Overview
12 .2.2 Product Overview
12 .2.3 Financial Overview
12 .2.4 Key Developments
12 .2.5 SWOT Analysis
12 .3 GE HEALTHCARE
12 .3.1 Company Overview
12 .3.2 Product Overview
12 .3.3 Financial Overview
12 .3.4 Key Development
12 .3.5 SWOT Analysis
12 .4 GE Healthcare
12 .4.1 Company Overview
12 .4.2 Product/Business Segment Overview
12 .4.3 Financial Overview
12 .4.4 Key Development
12 .4.5 SWOT Analysis
12 .5 Dispocard Gmbh
12 .5.1 Company Overview
12 .5.2 Product Overview
12 .5.3 Financial Overview
12 .5.4 Key Developments
12 .6 Terumo Medical Corporation
12 .6.1 Company Overview
12 .6.2 Product Overview
12 .6.3 Financial Overview
12 .6.4 Key Developments
12 .7 Johnson & Johnson
12 .7.1 Overview
12 .7.2 Product Overview
12 .7.3 Financials
12 .7.4 Key Developments
12 .7.5 SWOT Analysis
12 .8 Medtronic Inc
12 .8.1 Overview
12 .8.2 Product Overview
12 .8.3 Financials
12 .8.4 Key Developments
12 .8.5 SWOT Analysis
12 .9 Abbott
12 .9.1 Overview
12 .9.2 Product Overview
12 .9.3 Financials
12 .9.4 Key Developments
12 .9.5 SWOT Analysis
12 .10 Maquet Medical India Private Limited
12 .10.1 Overview
12 .10.2 Product Overview
12 .10.3 Financials
12 .10.4 Key Developments
12 .10.5 SWOT Analysis
12 .11 SMITHS MEDICAL
12 .11.1 Overview
12 .11.2 Product Overview
12 .11.3 Financials
12 .11.4 Key Developments
12 .11.5 SWOT Analysis
13 MRFR Conclusion
13 .1 Key Findings
13.1.1 From CEOβs View Point
13 .1.2 Unmet Needs of the Market
13 .2 Key Companies to Watch
13 .3 Prediction of the Pharmaceutical Industry
14 Appendix
LIST OF TABLES
Table 1 Cardiac catheterization Industry Synopsis, 2018β2027
Table 2 Global Cardiac catheterization Market Estimates and Forecast, 2018β2027, (USD Million)
Table 3 Global Cardiac catheterization Market, by Region, 2018β2027, (USD Million)
Table 4 Global Cardiac catheterization Market, by Types, 2018β2027, (USD Million)
Table 5 Global Cardiac catheterization Market, by Procedures, 2018β2027, (USD Million)
Table 6 Global Cardiac catheterization Market, by Application, 2018β2027, (USD Million)
Table 7 Global Cardiac catheterization Market, by End-User, 2018β2027, (USD Million)
Table 8 North America Cardiac catheterization Market, by Types, 2018β2027, (USD Million)
Table 9 North America Cardiac catheterization Market, by Application, 2018β2027, (USD Million)
Table 10 North America Cardiac catheterization Market, by Procedures, 2018β2027, (USD Million)
Table 11 North America Cardiac catheterization Market, by End-User, 2018β2027, (USD Million)
Table 11 US Cardiac catheterization Market, by Types, 2018β2027, (USD Million)
Table 13 US Cardiac catheterization Market, by Application, 2018β2027, (USD Million)
Table 14 US Cardiac catheterization Market, by Procedures, 2018β2027, (USD Million)
Table 15 US Cardiac catheterization Market, by End-User, 2018β2027, (USD Million)
Table 16 Canada Cardiac catheterization Market, by Types, 2018β2027, (USD Million)
Table 17 Canada Cardiac catheterization Market, by Procedures, 2018β2027, (USD Million)
Table 18 Canada Cardiac catheterization Market, by Application, 2018β2027, (USD Million)
Table 19 Canada Cardiac catheterization Market, by End-User, 2018β2027, (USD Million)
Table 20 South America Cardiac catheterization Market, by Types, 2018β2027, (USD Million)
Table 21 South America Cardiac catheterization Market, by Application, 2018β2027, (USD Million)
Table 22 South America Cardiac catheterization Market, by Procedures, 2018β2027, (USD Million)
Table 23 South America Cardiac catheterization Market, by End-User, 2018β2027, (USD Million)
Table 24 Europe Cardiac catheterization Market, by Procedure, 2018β2027, (USD Million
Table 25 Europe Cardiac catheterization Market, by Types, 2018β2027, (USD Million)
Table 26 Europe Cardiac catheterization Market, by Application, 2018β2027, (USD Million)
Table 27 Europe Cardiac catheterization Market, by End-User, 2018β2027, (USD Million)
Table 28 Western Europe Cardiac catheterization Market, by Procedure, 2018β2027, (USD Million)
Table 29 Western Europe Cardiac catheterization Market, by Types, 2018β2027, (USD Million)
Table 30 Western Europe Cardiac catheterization Market, by Application, 2018β2027, (USD Million)
Table 31 Western Europe Cardiac catheterization Market, by End-User, 2018β2027, (USD Million)
Table 32 Eastern Europe Cardiac catheterization Market, by Types, 2018β2027, (USD Million)
Table 33 Eastern Europe Cardiac catheterization Market, by Application, 2018β2027, (USD Million)
Table 34 Eastern Europe Cardiac catheterization Market, by End-User, 2018β2027, (USD Million)
Table 35 Asia-Pacific Cardiac catheterization Market, by Procedures, 2018β2027, (USD Million)
Table 36 Asia-Pacific Cardiac catheterization Market, by Types, 2018β2027, (USD Million)
Table 37 Asia-Pacific Cardiac catheterization Market, by Application, 2018β2027, (USD Million)
Table 33 Asia-Pacific Cardiac catheterization Market, by End-User, 2018β2027, (USD Million)
Table 34 Middle East & Africa Cardiac catheterization Market, by Types, 2018β2027, (USD Million)
Table 35 Middle East & Africa Cardiac catheterization Market, by Procedures, 2018β2027, (USD Million)
Table 36 Middle East & Africa Cardiac catheterization Market, by Application, 2018β2027, (USD Million)
Table 37 Middle East & Africa Cardiac catheterization Market, by End-User, 2018β2027, (USD Million)
β
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Cardiac catheterization Market
Figure 3 Segmentation Market Dynamics for Cardiac catheterization Market
Figure 4 Global Cardiac catheterization Market Share, by Types 2016
Figure 5 Global Cardiac catheterization Market Share, by Procedures 2016
Figure 6 Global Cardiac catheterization Market Share, by End-User, 2016
Figure 7 Global Cardiac catheterization Market Share, by Region, 2016
Figure 8 North America Cardiac catheterization Market Share, by Country, 2016
Figure 9 Europe Cardiac catheterization Market Share, by Country, 2016
Figure 10 Asia-Pacific Cardiac catheterization Market Share, by Country, 2016
Figure 11 Middle East & Africa Cardiac catheterization Market Share, by Country, 2016
Figure 12 Global Cardiac catheterization Market: Company Share Analysis, 2016 (%)
Figure 13 Becton, Dickinson And Company: Key Financials
Figure 14 Becton, Dickinson And Company: Segmental Revenue
Figure 15 Becton, Dickinson And Company: Geographical Revenue
Figure 16 Johnson & Johnson: Key Financials
Figure 17 Johnson & Johnson: Segmental Revenue
Figure 18 Johnson & Johnson: Geographical Revenue
Figure 19 Terumo Medical Corporation: Key Financials
Figure 20 Terumo Medical Corporation: Segmental Revenue
Figure 21 Terumo Medical Corporatio006E: Geographical Revenue
Figure 22 GE Healthcare: Key Financials
Figure 23 GE Healthcare.: Segmental Revenue
Figure 24 GE Healthcare: Geographical Revenue
Figure 25 Maquet Medical India Private Limited: Key Financials
Figure 26 Maquet Medical India Private Limited: Segmental Revenue
Figure 27 Maquet Medical India Private Limited: Geographical Revenue
Figure 28 SMITHS MEDICAL: Key Financials
Figure 29 SMITHS MEDICAL Segmental Revenue
Figure 30 SMITHS MEDICAL Geographical Revenue
Cardiac Catheterization Market
The cardiac catheterization market is anticipated to grow at USD 13.34 Billion at a 7.8% CAGR from 2022-2030
$13.34 Billion
Market Size
7.8%
CAGR
North America
Dominating Region
2022-2030
Forecast Period
Segmentation
Key Players
- Jude Medical (US)
- Medtronic Inc. (US)
- Becton
- Dickinson and Company (US)
- Terumo Medical Corporation (Japan)
- Teleflex Incorporated (US)
- Edwards Life Sciences Corporation (US)
- Abbott (US)
- Boston Scientific Corporation (US)
- Rochester Medical Corporation (US)
- Johnson & Johnson Private Limited (US)
- Dispocard GmbH (Germany)
- Maquet Medical India Private Limited (India)
- Coloplast (Denmark)
Drivers
- Increasing Number of Technologically Advanced Devices.
Cardiac Catheterization Market Overview
The cardiac catheterization market is anticipated to grow at a high speed in the years to come. The heart catheterization market value is anticipated to grow at a CAGR of 9.2%. This is because of increasing technological advancements in medical devices and the rising number of cardiac diseases among the global population.
Cardiac catheterization refers to a procedure to test the operation of the heart. It is also used to diagnose or cure cardiovascular conditions. The heart catheterization market is fueled by the increase in technologically advanced medical devices, regulatory approvals, geriatric population, alcohol abuse, and the prevalence of cardiac disorders such as cardiac arrhythmias, ventricular fibrillation, and ventricular tachycardia.
Covid-19 Analysis
With the rise of the Covid-19 impact, many large-scale businesses and industries suffered, except healthcare and life support products. The lockdown and physical distancing protocols have affected millions of small and big business institutions alike. The heart catheterization market saw a slight downfall post the pandemic, due to the lockdown and physical distancing.
However, the key companies have adopted measures to expand the distribution of cardiac catheters across the globe. Moreover, people are growing aware of cardiac diseases and the need for a heart catheterization. Hence, these factors are expected to boost the growth of the cardiac catheterization market value in the years to come.
Market Dynamics
Drivers
A few factors may drive the growth of the cardiac catheterization market share. There have been increasing cases of cardiac disorders such as cardiac arrhythmias, ventricular fibrillation, and ventricular tachycardia. These cases have contributed to the boost in awareness about healthcare in the people and innovations in the devices. Moreover, the government has been rendering strong support to the development of the market through reimbursement policies and research & development investments. Hence, these factors are expected to accelerate global market growth.
Opportunities
The major companies that account for the largest cardiac catheterization market share are adopting various trends such as new product launches with advanced technology for diagnosis and treatment. There has also been a rise in the average income of the global population, which has fueled the healthcare expenditure. Hence, these factors serve as opportunities for global market growth.
Restraints
There are a few factors that may inhibit the cardiac catheterization market growth. One of the most important of them is the high cost of the catheters and surgical procedures for catheterization. Moreover, these catheters are more likely to come with a few side effects on the patients who undergo the procedure. Hence, these factors may hinder market growth.
Challenges
Some factors that may challenge the key catheterization device providers include the cost of the catheters. They are quite expensive and are not affordable to a majority of patients with cardiac disorders. Moreover, there is a lack of healthcare infrastructure in many places. The population may also not be aware of cardiac diseases such as cardiac arrhythmias and ventricular tachycardia. Hence, these factors challenge the key players of the global market.
Cumulative Growth Analysis
The cardiac catheterization market is anticipated to grow at high speed in the years to come. The heart catheterization market value is anticipated to reach up to USD 20.8 billion over the forecast period, with a CAGR (Compound Annual Growth Rate) of about 9.2%. This is because of increasing technological advancements in medical devices and the rising share of cardiac diseases among the global population.
Value Chain Analysis
People are growing aware of the numerous heart diseases and the need for cardiac catheterization. These catheter devices are growing popular because of their ability to diagnose various heart diseases and cardiovascular conditions. Many key companies of the market have also adopted trends such as innovations and product launches. The government is also supporting market research and development, along with many reimbursement policies for the same. Hence, these factors may fuel the growth of the industry in the global cardiac catheterization market forecast.
Segment Overview
The cardiac catheterization market is classified into many segments such as types and beauty. Listed below are the heart catheterization market segments:
By Types
- Fractional Flow Reserve
- Optical Coherence Tomography
- Intravascular Ultrasound
- Coronary Angiogram
By Procedures
- Catheter Ablation
- Coronary Angioplasty
- Bipolar Pacing
- Balloon septostomy
- Right Heart Catheterization
- Left Heart Catheterization
- Others
By Application
- Heart Attack
- Cardiac Arrhythmia
- Coronary Vasospasm
- Abnormal Stress Test
- Others
By End-user
- Hospitals & clinics
- Others
Regional Analysis
The regional division of the cardiac catheterization market analysis comprises North America, Europe, Asia Pacific, and the rest of the world. Among these regions, the Americas are expected to rule over the global market over the forecast period (2022 – 2027). This is because most of the populations in this region are older and geriatric, with a high share of cardiovascular diseases among adults.
Moreover, obesity and hypertension are other causes of cardiac disorders in the region. Moreover, advanced medical treatment provisions are expected to fuel the demand for a heart catheterization. This region will be followed by Europe, with the second-largest share in the global cardiac catheterization industry. This is because of the demand for better healthcare infrastructure and the initiatives for healthcare reforms by the government in the region.
However, the Asia Pacific region is anticipated to witness the fastest market growth rate over the forecast period. This is because the Asia Pacific comprises a large share of the diabetic population. This is because of the high concentration of the diabetic and geriatric population in the region. Moreover, the government has aided the market growth with favorable reimbursement and insurance policies. However, the Middle East and Africa region are expected to see slow growth due to lack of awareness, availability of treatment facilities, and limited access to them.
Competitive Landscape
The cardiac catheterization industry is dominated by a few companies that play a vital role in the market growth. These heart catheter companies are called key companies of the market. They contribute to the largest share of the market profit.
The companies account for the market profits by adopting various cardiac catheterization market trends such as joint ventures, product launches, company expansions, and procurements. They are innovative catheterization options for patients suffering from cardiac diseases.
Key Players
Below are the key companies that offer cardiac catheterization in the global market, with the location of their headquarters:
- Jude Medical (US)
- Medtronic Inc. (US)
- Becton, Dickinson, and Company (US)
- Terumo Medical Corporation (Japan)
- Teleflex Incorporated (US)
- Edwards Life Sciences Corporation (US)
- Abbott (US)
- Boston Scientific Corporation (US)
- Rochester Medical Corporation (US)
- Johnson & Johnson Private Limited (US)
- Dispocard GmbH (Germany)
- Maquet Medical India Private Limited (India)
- Coloplast (Denmark)
- Smiths Medical (US)
Recent Developments
- Medtronic Inc. and Boston Scientific Corporation established their regional headquarters and manufacturing plants in Japan, Korea, Singapore, China, and Australia. This is to fuel the cardiac catheterization market in the Asia Pacific.
Report Overview
This report delivers all the information about the growth of the global cardiac catheterization market size in the forecast period. It also contains different sections of the market analysis to help obtain detailed information such as opportunities, challenges, drivers, Covid-19 analysis, regional analysis, competitive landscape, and others. Moreover, all the information is collected from verified primary and secondary sources to provide the expected cardiac catheterization market outlook by the year 2027.
Geographically
- Europe
- Asia-Pacific
- North America
- Middle East & Africa
- Rest of the world
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2027: Significant Value |
| CAGR | 9.2% (2020-2027) |
| Base Year | 2018 |
| Forecast Period | 2027 |
| Historical Data | 2017 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Procedure, Types, Application, End-User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Boston Scientific Corporation (US), Coloplast (Denmark), Dispocard GmbH (Germany), Becton, Dickinson and Company (US), St. Jude Medical (US), Abbott (US), Johnson & Johnson Private Limited (US), Teleflex Incorporated (US)., Smiths Medical (US), Edwards Life Sciences Corporation (US), Medtronic Inc (US), Rochester Medical Corporation (U.S), Maquet Medical India Private Limited (India), Terumo Medical Corporation (Japan) |
| Key Market Opportunities |
|
| Key Market Drivers | Increasing Number of Technologically Advanced Devices. |
Frequently Asked Questions (FAQ) :
The cardiac catheterization market is predicted to grow at a 9.2% CAGR between 2018-2027.
The Americas is predicted to dominate the cardiac catheterization market.
Increasing prevalence of cardiac diseases, favorable reimbursement policies, and rising awareness of healthcare are boosting market growth.
Side effects, lack of proper healthcare infrastructure, and high cost may limit market growth.
It is mostly used to treat and diagnose cardiac arrhythmia, coronary vasospasm, and heart attack.
